Cargando…

PSMA Targeted Molecular Imaging and Radioligand Therapy for Prostate Cancer: Optimal Patient and Treatment Issues

Theranostics (therapy + diagnosis) targeting prostate-specific membrane antigen (PSMA) is an emerging therapeutic modality that could alter treatment strategies for prostate cancer. Although PSMA-targeted radioligand therapy (PSMA-RLT) has a highly therapeutic effect on PSMA-positive tumor tissue, t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hoshi, Seiji, Yaginuma, Kei, Meguro, Satoru, Onagi, Akifumi, Matsuoka, Kanako, Hata, Junya, Sato, Yuichi, Akaihata, Hidenori, Kataoka, Masao, Ogawa, Soichiro, Uemura, Motohide, Kojima, Yoshiyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10453875/ https://www.ncbi.nlm.nih.gov/pubmed/37623010 http://dx.doi.org/10.3390/curroncol30080529

Ejemplares similares

Role of puboperinealis and rectourethralis muscles as a urethral support system to maintain urinary continence after robot-assisted radical prostatectomy
por: Kataoka, Masao, et al.
Publicado: (2023)

Mechanism of Androgen-Independent Stromal Proliferation in Benign Prostatic Hyperplasia
por: Hata, Junya, et al.
Publicado: (2023)

Unilateral adrenalectomy for a drug-resistant bilateral primary aldosteronism with heart failure: pathophysiology and surgical indication
por: Hoshi, Seiji, et al.
Publicado: (2023)

l-Theanine Protects Bladder Function by Suppressing Chronic Sympathetic Hyperactivity in Spontaneously Hypertensive Rat
por: Matsuoka, Kanako, et al.
Publicado: (2021)

Involvement of Mast-Cell-Tryptase- and Protease-Activated Receptor 2—Mediated Signaling and Urothelial Barrier Dysfunction with Reduced Uroplakin II Expression in Bladder Hyperactivity Induced by Chronic Bladder Ischemia in the Rat
por: Akaihata, Hidenori, et al.
Publicado: (2023)

SMARCB1‐deficient basal cell carcinoma of the prostate controlled using radiation therapy
por: Makabe, Shunta, et al.
Publicado: (2023)

Upregulation of glucocorticoid receptor‐mediated glucose transporter 4 in enzalutamide‐resistant prostate cancer
por: Hoshi, Seiji, et al.
Publicado: (2021)

Spindle cell renal cell carcinoma diagnosed after sunitinib treatment for chromophobe renal cell carcinoma
por: Honda‐Takinami, Ruriko, et al.
Publicado: (2020)

Association Between Surgical Stress and Biochemical Recurrence After Robotic Radical Prostatectomy
por: Meguro, Satoru, et al.
Publicado: (2021)

Impacts of Neoadjuvant Hormonal Therapy Prior to Robot-Assisted Radical Prostatectomy on Postoperative Hormonal- and Sexual-Related Quality of Life – Assessment by Patient-Reported Questionnaire
por: Ogawa, Soichiro, et al.
Publicado: (2022)

The current status of prostate cancer treatment and PSMA theranostics
por: Uemura, Motohide, et al.
Publicado: (2023)

Delayed diagnosis of intraperitoneal bladder perforation after blunt trauma
por: Wang, Lu, et al.
Publicado: (2019)

Association between the presence of bacteria in prostate tissue and histopathology in biopsies from men not complaining of lower urinary tract symptoms
por: Honda-Takinami, Ruriko, et al.
Publicado: (2022)

Tetrahydrobiopterin prevents chronic ischemia-related lower urinary tract dysfunction through the maintenance of nitric oxide bioavailability
por: Akaihata, Hidenori, et al.
Publicado: (2020)

Renal-type Clear Cell Carcinoma Occurring in the Prostate With Zinner Syndrome
por: Sato, Yuichi, et al.
Publicado: (2016)

Infrarenal high intra-abdominal testis: fusion of T2-weighted and diffusion-weighted magnetic resonance images and pathological findings
por: Hoshi, Seiji, et al.
Publicado: (2017)

Suppression of SOCS3 enhances TRAIL-induced cell growth inhibition through the upregulation of DR4 expression in renal cell carcinoma cells
por: Yabe, Michihiro, et al.
Publicado: (2018)

Complement activation by autoantigen recognition in the growth process of benign prostatic hyperplasia
por: Hata, Junya, et al.
Publicado: (2019)

The Effect of the Vesical Adaptation Response to Diuresis on Lower Urinary Tract Symptoms after Robot-Assisted Laparoscopic Radical Prostatectomy: A Pilot Proof of Concept Study
por: Haga, Nobuhiro, et al.
Publicado: (2016)

Cavernous hemangioma in the bladder of an 8-year-old boy
por: Hasegawa, Akihisa, et al.
Publicado: (2023)

Coincidental occurrence of bilateral neonatal testicular torsion, with an extravaginal and a contralateral intravaginal testicular torsion
por: Kirihana, Yusuke, et al.
Publicado: (2023)

The great East Japan earthquake affected the laboratory findings of hemodialysis patients in Fukushima
por: Haga, Nobuhiro, et al.
Publicado: (2013)

Metal-Based PSMA Radioligands
por: Gourni, Eleni, et al.
Publicado: (2017)

A giant prostatic hyperplasia treated by open surgery
por: Ogawa, Soichiro, et al.
Publicado: (2012)

Pharmacological Optimization of PSMA-Based Radioligand Therapy
por: van der Gaag, Suzanne, et al.
Publicado: (2022)

Congenital lipoid adrenal hyperplasia: Immunohistochemical study of testosterone synthesis in Leydig cells
por: Matsuoka, Kanako, et al.
Publicado: (2020)

PSMA Theranostics: Review of the Current Status of PSMA-Targeted Imaging and Radioligand Therapy
por: Jones, Wallace, et al.
Publicado: (2020)

Uni-axial stretch induces actin stress fiber reorganization and activates c-Jun NH(2) terminal kinase via RhoA and Rho kinase in human bladder smooth muscle cells
por: Kushida, Nobuhiro, et al.
Publicado: (2016)

Design, Synthesis, and Evaluation of Linker-Optimised PSMA-Targeting Radioligands
por: Lundmark, Fanny, et al.
Publicado: (2022)

Analysis of PSMA expression and outcome in patients with advanced Prostate Cancer receiving (177)Lu-PSMA-617 Radioligand Therapy
por: Seifert, Robert, et al.
Publicado: (2020)

(177)Lu-PSMA radioligand therapy of predominant lymph node metastatic prostate cancer
por: von Eyben, Finn Edler, et al.
Publicado: (2019)

Albumin-Binding PSMA Radioligands: Impact of Minimal Structural Changes on the Tissue Distribution Profile
por: Deberle, Luisa M., et al.
Publicado: (2020)

Development of a new class of PSMA radioligands comprising ibuprofen as an albumin-binding entity
por: Deberle, Luisa M., et al.
Publicado: (2020)

Factors Influencing the Therapeutic Efficacy of the PSMA Targeting Radioligand (212)Pb-NG001
por: Stenberg, Vilde Yuli, et al.
Publicado: (2022)

PSMA Radioligand Uptake as a Biomarker of Neoangiogenesis in Solid Tumours: Diagnostic or Theragnostic Factor?
por: Rizzo, Alessio, et al.
Publicado: (2022)

Status of PSMA-targeted radioligand therapy in prostate cancer: current data and future trials
por: Jang, Albert, et al.
Publicado: (2023)

Joint EANM/SNMMI procedure guideline for the use of (177)Lu-labeled PSMA-targeted radioligand-therapy ((177)Lu-PSMA-RLT)
por: Kratochwil, Clemens, et al.
Publicado: (2023)

Repeated PSMA-targeting radioligand therapy of metastatic prostate cancer with (131)I-MIP-1095
por: Afshar-Oromieh, Ali, et al.
Publicado: (2017)

Streamlined Schemes for Dosimetry of (177)Lu-Labeled PSMA Targeting Radioligands in Therapy of Prostate Cancer
por: Kurth, Jens, et al.
Publicado: (2021)

Impact of the mouse model and molar amount of injected ligand on the tissue distribution profile of PSMA radioligands
por: Tschan, Viviane J., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_puc2t4fblhf7dojrqpipktkg0b